Eira Ana, Gonçalves Maria Beatriz S, Fongang Yannick Stéphane Fotsing, Domingues Cátia, Jarak Ivana, Mascarenhas-Melo Filipa, Figueiras Ana
Laboratory of Drug Development and Technologies, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal.
Higher Teachers' Training College, The University of Maroua, Maroua P.O. Box 55, Cameroon.
Pharmaceutics. 2025 Mar 26;17(4):422. doi: 10.3390/pharmaceutics17040422.
(), commonly known as the "Lingzhi" or "Reishi" mushroom, has long been recognized for its potential health benefits and medicinal properties in traditional Chinese medicine. The unique potential combination of bioactive compounds present in , such as triterpenoids, polysaccharides, and peptides, has inspired interest in leveraging their therapeutic potential In recent years, the emerging field of nanotechnology has opened up new possibilities for using the remarkable properties of at the nanoscale. The main objective of this review is to explore the unique potential of in traditional and innovative therapies, particularly in cancer treatment, and to assess how nanotechnology-based strategies can enhance its therapeutic applications.is to explore. Nanotechnology-based strategies have been investigated for the efficient extraction and purification of bioactive compounds from . Additionally, nanocarriers and nanoformulations have been developed to protect these sensitive bioactive compounds from degradation, ensuring their stability during storage and transportation. The use of -based nanomaterials has shown promising results in several biomedical applications, namely due to their anticancer activity by targeting cancer cells, inducing apoptosis, and inhibiting tumor growth. The combination of and nanotechnology presents an exciting frontier in the development of novel therapeutic and biomedical applications. Nevertheless, further research and development in this interdisciplinary field are warranted to fully exploit the synergistic benefits offered by and nanotechnology. Future prospects include the development of robust clinical trials focused on nanotechnology-based cancer therapies to clarify mechanisms of actions and optimize formulations, ultimately leading to innovative solutions for human health and well-being.
J Pharm Pharmacol. 2024-12-2
Int J Biol Macromol. 2023-12-31
Antioxidants (Basel). 2023-10-25
Front Oncol. 2024-4-10
J Clin Med. 2024-2-18